" class="no-js "lang="en-US"> Inhalon Biopharma Archives - Medtech Alert
Wednesday, February 08, 2023

Sort by:

Date

Top Post

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience

Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]

Inhalon Doses First Patient in Phase 1 Study of Inhaled IN-006 to Treat COVID-19

Inhalon Biopharma, Inc., a clinical-stage immunotherapy company developing an inhaled “muco-trapping” antibody platform for treating […]

  1. Tvardi Therapeutics Appoints John Kauh, M.D. as Chief Medical Officer Read more
  2. Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S. Read more
  3. Spectrum Science Receives Strategic Investment from Knox Lane to Fuel Continued Growth Read more
  4. Synergy Health Partners Selects Dr. Richard L. Makowiec as Chief Surgical Officer Read more
  5. TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials Read more